Schoumacker et al.
8.4, 4.2 Hz); 2.57 (hept, 1H, J ) 6.3 Hz); 1.35 (d, 3H, J ) 6.3
Hz, 3H); 1.30 (d, 3H, J ) 6.3 Hz). 13C NMR (76 MHz, CDCl3)
δ: 150.0 (CH); 147.3 (C); 136.1 (CH); 133.1 (C); 128.9 (CH);
127.8 (C); 127.2 (CH); 126.4 (CH); 121.3 (CH); 76.9 (CH); 62.7
(CH); 21.4 (CH3); 18.9 (CH3). IR: 3037, 2972, 2932, 2877, 1596,
1583, 1503, 1468, 1361, 1261, 1232, 1159, 884, 822, 792, 765,
627. ESI-MS, m/z: 277.1 (45) [6 + H]+; 260.1 (100) [6 - OH]+.
Anal. Calcd for C13H14N2: C, 72.87; H, 6.59; N, 13.07; O, 7.47.
Found: C, 72.95; H, 6.61; N, 12.98.
(1-Phenylethyl)[2]pyridinylmethyleneamine (7). Under
a nitrogen atmosphere, a solution of 1(S)-phenylethylamine
(1.14 g; 9.43 mmol) in methanol (20 mL) was added over 30
min to a cooled (0 °C) solution of freshly distilled 2-pyridin-
ecarboxaldehyde (1.11 g; 10.4 mmol) in methanol (75 mL). The
resulting yellow solution was stirred for an additional 1 h at
room temperature. Concentration in vacuo afforded the crude
product as a yellow oil. The oxaziridine was purified by silica
gel column chromatography (ethyl acetate/hexane ) 2/8)
previously treated with Et3N, and 7was obtained as a yellow
oil (1.72 g; 8.19 mmol; 87%). [R]25D: +85 (c 0.6, CHCl3). 1H
NMR (300 MHz, CDCl3) δ: 8.29 (s, 1H); 8.60 (ddd, 1H, J )
4.8, 1.5, 0.9 Hz); 8.45 (s, 1H); 8.08 (dd, 1H, J ) 7.8, 0.9 Hz);
7.74 (ddd, 1H, J ) 7.8, 7.5, 1.5 Hz); 7.42 (d, 2H, J ) 7.2 Hz);
7.33 (dd, 2H, J ) 7.2, 7.2 Hz); 7.27 (ddd, 1H, J ) 7.5, 1.2, 1.2
Hz); 7.25 (t, 1H, J ) 7.2 Hz); 4.63 (q, 1H, J ) 6.6 Hz); 1.60 (d,
3H, J ) 6.6 Hz). 13C NMR (76 MHz, CDCl3) δ: 160.4 (CH);
154.7 (C); 149.2 (CH); 144.5 (C); 136.5 (CH); 128.4 (CH); 127.0
(CH); 126.6 (CH); 124.7 (CH); 121.4 (CH); 69.5 (CH); 24.4
(CH3). IR: 3060, 3028, 2972, 2927, 2862, 1647, 1568, 1468,
1371, 968, 763, 700 cm-1. ESI-MS, m/z: 233.1 (40) [7 + Na]+;
224.1 (100) [(7)2 + Na]+.
9 was obtained as pale yellow crystals (471 mg; 1.64 mmol;
1
82%). [R]25
D: -5 (c 0.19, CHCl3). H NMR (300 MHz, CDCl3)
δ: 8.74 (d, 1H, J ) 4.8 Hz); 8.48 (d, 1H, J ) 4.8 Hz); 8.29 (d,
1H, J ) 8.1 Hz); 7.75 (ddd, 1H, J ) 15.6, 7.5, 1.8 Hz); 7.40-
7.10 (m, 9H); 4.58 (q, 1H, J ) 6.3 Hz); 1.53 (d, 3H, J ) 6.3
Hz). 13C NMR (76 MHz, CDCl3) δ: 164.9 (C); 157.2 (C); 155.6
(C); 149.7 (CH); 148.7 (CH); 145.2 (CH); 136.3 (CH); 135.9
(CH); 126.7 (CH); 126.6 (CH); 124.0 (CH); 124.0 (CH); 123.4
(CH); 123.0 (CH); 122.5 (CH); 61.4 (CH); 24.5 (CH3). IR: 3061,
3029, 2979, 2932, 1590, 1571, 1437, 1387, 991, 772, 698 cm-1
.
ESI-MS m/z: 288.0 (100) [9 + H]+; 310.1 (45) [9 + Na]+; 596.8
(45) [(9)2 + Na]+. Anal. Calcd for C19H17N3: C, 79.41; H, 5.96;
N, 14.62. Found: C, 79.36; H, 6.01; N, 14.63.
3,3-Bispyridinyl-2-(1-methylbenzyl)oxaziridine (10).
To a solution of 9 (240 mg; 836 µmol) in acetonitrile (20 mL),
cooled to 0 °C, were successively added a solution of NaHCO3
(281 mg; 3.35 mmol) in water (10 mL) and, over a 1 h period,
a solution of KHSO5 (770 mg; 1.25 mmol) in water (20 mL).
The resulting solution was vigorously stirred for completion
for an additional 1 h at room temperature. After extraction
with CHCl3, the organic layer was dried over Na2SO4 and the
solvent was evaporated to afford a pale yellow oil. The crude
product was obtained as a yellow oil. Purification by silica gel
(previously treated with Et3N) chromatography using chro-
matotron apparatus (ethyl acetate/hexane ) 3/7) yielded 10
as a colorless oil (200 mg, 660 µmol, 79%). [R]25D: +10 (c 0.10,
CHCl3). 1H NMR (300 MHz, CDCl3) δ: 8.50-8.44 (m, 2H); 7.73
(ddd, 1H, J ) 7.8, 7.8, 1.8 Hz); 7.70-7.68 (m, 1H); 7.67 (ddd,
1H, J ) 7.8, 7.8, 1.8 Hz); 7.58 (ddd, 1H, J ) 7.8, 1.2, 0.9 Hz);
7.28 (ddd, 1H, J ) 7.5, 4.8, 1.2 Hz); 7.23-7.18 (m, 3H); 7.17
(ddd, 1H, J ) 6.3, 4.8, 2.7 Hz); 6.97-6.91 (m, 2H); 3.27 (q, 1H,
J ) 6.3 Hz); 1.62 (d, 3H, J ) 6.3 Hz). 13C NMR (76 MHz,
CDCl3) δ: 157.4 (C); 153.8 (C); 149.0 (CH); 148.9 (CH); 139.9
(C); 136.7 (CH); 135.7 (CH); 128.3 (CH); 127.7 (CH); 127.2
(CH); 124.4 (CH); 123.7 (CH); 123.6 (CH); 122.6 (CH); 86.6 (C);
63.2 (CH); 22.9 (CH3). IR: 3061, 3029, 2973, 2931, 1641, 1570,
1442, 1390, 975, 765, 697 cm-1. ESI-MS m/z: 286.2 (100) [10
- H]+; 325.9 (10) [10 + Na]+. Anal. Calcd for C19H17N3O: C,
75.23; H, 5.65; N, 13.85. Found: C, 75.27; H, 5.61; N, 13.90.
Crystallographic data: orthorombic, P2(1)2(1)2(1) a ) 8.0723-
(16) Å, b ) 12.111(2) Å, c ) 34.684(7) Å, V ) 3391.0(12) Å3, Z
) 8, R ) 0.0462, Rw ) 0.0825.
Standard Conditions for Sulfoxidation Were As Fol-
lows: To a solution of the oxaziridine (100 µmol) in 8.3 mL of
solvent were successively added sulfide (83 µmol) and Lewis
acid (100 µmol) (1.2:1.2:1 oxaziridine/Lewis acid/sulfide ratio).
An internal standard (30 µL of a 1 M solution of benzophenone
or fluorenone in toluene) was added to the reaction mixture.
The characterization of the sulfoxides was done by GC-MS.
Unambiguous identification of the products was made by
comparison with pure compounds, which were either prepared
independently or commercially available. All the sulfoxides
were isolated by column chromatography on silica gel (ethyl
acetate/hexane ) 20/80 then 80/20). The enantiomeric excesses
were determined by 1H NMR in CDCl3 for the purified products
as follows: 1-2 equiv of (R)-(+)-2,2′-binaphthol were added
by small portions until a good splitting of the CH3 singlet
(between 2.7 and 3.0 ppm) was obtained.21 The ee was
calculated from the deconvolution of these two peaks.
3-Pyridinyl-2-(1-me´thylbenzyl)oxaziridine (8). To a
vigorously stirred solution of 7 (336 mg; 1.6 mmol) in aceto-
nitrile (20 mL) cooled to 0 °C were successively added a
solution of NaHCO3 (538 mg; 6.4 mmol) in water (20 mL) and,
over 30 min, a solution of KHSO5 (1.47 g; 2.39 mmol) in water
(20 mL). After extraction with CHCl3 the solution was dried
over Na2SO4 and concentrated in vacuo. The crude product
was obtained as a yellow oil containing three stereoisomers
(1:4:9.3 ratio). Silica gel chromatographic purification using
chromatotron apparatus (ethyl acetate/hexane ) 15/85) previ-
ously treated with Et3N afforded 8a as a colorless solid (128
mg, 35%) and 8b as a colorless oil (160 mg, 50%). 8a. [R]25
:
D
1
+59 (c 0.5, CHCl3). H NMR (300 MHz, CDCl3) δ: 8.59 (ddd,
1H, J ) 4.8, 1.5, 0.9 Hz); 7,70 (ddd, 1H, J ) 7.5, 7.5, 1.8 Hz);
7.60 (m, 2H); 7.37 (m, 3H); 7.28-7.34 (m, 2H); 4.85 (s, 1H);
3.42 (q, 1H, J ) 6.9 Hz); 1.53 (d, 3H, J ) 6.9 Hz). 13C NMR
(76 MHz, CDCl3) δ: 154.8 (C); 149.0 (CH); 141.6 (C); 136.9
(CH); 128.5 (CH); 127.6 (CH); 127.0 (CH); 124.6 (CH); 121.5
(CH); 80.5 (CH); 70.3 (CH); 19.5 (CH3). IR: 3062, 3029, 2979,
2932, 1593, 1572, 1439, 1390, 1083, 995, 776, 698 cm-1
.
Crystallographic data: orthorombic, P2(1)2(1)2(1), a ) 15.139-
(3) Å, b ) 7.9773(16) Å, c ) 10.163(2) Å, V ) 1227.4(4) Å3, Z
) 4, R ) 0.0492, Rw ) 0.0887. 8b. [R]25D: -38 (c 0.5, CHCl3).
1H NMR (300 MHz, CDCl3) δ: 8.48 (ddd, 1H, J ) 4.8, 1.5, 0.9
Hz); 7.65 (ddd, 1H, J ) 7.5, 1.8, 1.8 Hz); 7.5-7.2 (m, 7H); 4.81
(s, 1H); 3.34 (q, 1H, J ) 6.3 Hz); 1.66 (d, 3H, J ) 6.3 Hz). 13
C
NMR (76 MHz, CDCl3) δ: 154.6 (C); 149.0 (CH); 139.5 (C);
136.8 (CH); 128.7 (CH); 128.0 (CH); 127.3 (CH); 124.5 (CH);
121.5 (CH); 80.4 (CH); 71.2 (CH); 21.5 (CH3). IR: 3062, 3029,
2979, 2932, 1593, 1572, 1439, 1390, 1083, 995, 776, 698 cm-1
.
ESI-MS m/z: 209.2 (100) [8b - H]+; 227.0 (15) [8b + H]+; 248.9
(22) [8b + Na]+; 444.1 (55) [(8b)2 + Na]+. Anal. Calcd for
C14H14N2O: C, 74.31; H, 6.24; N, 12.38. Found: C, 74.28; H,
6.30; N, 12.39.
Acknowledgment. We are grateful to the “Minis-
te`re Franc¸ais de la Recherche et de la Technologie” for
an “ACI Jeunes Chercheurs 2000” grant. We also thank
C. Lebrun (DRFMC, CEA-Grenoble) for the ES-MS
analysis.
(1-Phenylethyl)[2]bispyridinylmethyleneamine (9). Un-
der a nitrogen atmosphere, a solution of 2,2-dipyridinyl ketone
(368.4 mg; 2.0 mmol), 1(S)-phenylethylamine (262 mg; 2.0
mmol), and boron trifluoride diethyl etherate (30 µL; 0.24
mmol) in toluene (25 mL) was refluxed for 24 h using Dean-
Stark apparatus. The resulting orange solution was concen-
trated in vacuo yielding the crude product as an orange oil.
The residue was purified by silica gel column chromatography
(ethyl acetate/hexane ) 3/7) previously treated with Et3N and
Supporting Information Available: 1H and 13C NMR
spectra of all the compounds excepted 1 and 4 and X-ray
crystallographic data for the ZnCl2(2) complex, 8a, and 10. This
material is available free of charge via the Internet at
JO048380K
308 J. Org. Chem., Vol. 70, No. 1, 2005